Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 2/20 | 0.55 |
| ▸ | LMNA | P02545 | 4/20 | 0.54 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.54 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.54 |
| ▸ | MAPK1 | P28482 | 5/20 | 0.52 |
| ▸ | GMNN | O75496 | 3/20 | 0.52 |
| ▸ | MAPT | P10636 | 3/20 | 0.52 |
| ▸ | NPSR1 | Q6W5P4 | 3/20 | 0.52 |
| ▸ | MEN1 | O00255 | 3/20 | 0.52 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.52 |
| ▸ | HSP90AA1 | P07900 | 2/20 | 0.52 |
| ▸ | BLM | P54132 | 2/20 | 0.52 |
| ▸ | NR1H4 | Q96RI1 | 2/20 | 0.52 |
| ▸ | TP53 | P04637 | 1/20 | 0.52 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.52 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.52 |
| ▸ | GLA | P06280 | 1/20 | 0.51 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.51 |
| ▸ | PAM | P19021 | 1/20 | 0.45 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9625918 | 0.89 | MEN1 (0.60) | TSHRLMNASMN1; SMN2CYP1A2MAPK1 | |
| SCHEMBL22207949 | 0.79 | LMNA (0.57) | TSHRLMNASMN1; SMN2CYP1A2MAPK1 | |
| SCHEMBL28314908 | 0.79 | LMNA (0.49) | TSHRLMNASMN1; SMN2CYP1A2MAPK1 | |
| SCHEMBL28916570 | 0.76 | LMNA (0.62) | TSHRLMNASMN1; SMN2CYP1A2MAPK1 | |
| SCHEMBL19923321 | 0.76 | LMNA (0.62) | TSHRLMNASMN1; SMN2CYP1A2MAPK1 | |
| SCHEMBL19923320 | 0.76 | LMNA (0.62) | TSHRLMNASMN1; SMN2CYP1A2MAPK1 | |
| SCHEMBL20742884 | 0.76 | LMNA (0.62) | TSHRLMNASMN1; SMN2CYP1A2MAPK1 | |
| SCHEMBL25287108 | 0.76 | MEN1 (0.58) | TSHRLMNACYP1A2MAPK1GMNN | |
| SCHEMBL12152228 | 0.76 | CYP1A2 (0.47) | TSHRLMNASMN1; SMN2CYP1A2MAPK1 | |
| Levocarnitine Propionate SCHEMBL12137155 | 0.76 | MEN1 (0.72) | TSHRLMNASMN1; SMN2CYP1A2MAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260034086-A1 | Pet Food Compositions Comprising Caprylic Acid And Docosahexaenoic Acid And/Or Eicosapetaenoic Acid For Use In Treating Struvite Urolithiasis | HILL'S PET NUTRITION, INC. (US) | 2026-02-05 | — | — | US | disclosed |
| US-12458617-B2 | Pet food compositions comprising caprylic acid and docosahexaenoic acid and/or eicosapetaenoic acid for use in treating struvite urolithiasis | HILL'S PET NUTRITION, INC. (US) | 2025-11-04 | — | — | US | disclosed |
| EP-3709817-B2 | COMPOSITIONS COMPRISING OMEGA-3 POLYUNSATURATED AND MEDIUM CHAIN FATTY ACIDS | HILLS PET NUTRITION INC (US) | 2025-10-22 | — | — | EP | disclosed |
| EP-3709817-B1 | COMPOSITIONS COMPRISING OMEGA-3 POLYUNSATURATED AND MEDIUM CHAIN FATTY ACIDS | HILLS PET NUTRITION INC (US) | 2022-11-16 | — | — | EP | disclosed |
| US-20220202759-A1 | Pet Food Compositions Comprising Caprylic Acid and Docosahexaenoic Acid and/or Eicosapetaenoic Acid for Use in Treating Struvite Urolithiasis | HILL'S PET NUTRITION, INC. (US) | 2022-06-30 | — | — | US | disclosed |
| US-10973244-B2 | Compositions comprising omega-3 polyunsaturated and medium chain fatty acids | HILLS PET NUTRITION, INC. (US) | 2021-04-13 | — | — | US | disclosed |
| US-20200296996-A1 | Compositions Comprising Omega-3 Polyunsaturated and Medium Chain Fatty Acids | HILL'S PET NUTRITION, INC. (US) | 2020-09-24 | — | — | US | disclosed |
| US-20190156919-A1 | DETERMINING RELATIONSHIPS BETWEEN RISKS FOR BIOLOGICAL CONDITIONS AND DYNAMIC ANALYTES | ARIVALE, INC. (US) | 2019-05-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260034086-A1 | Pet Food Compositions Comprising Caprylic Acid And Docosahexaenoic Acid And/Or Eicosapetaenoic Acid For Use In Treating Struvite Urolithiasis | FPR2, FPR1, FPR3 | TSHR 764/4885LMNA 1957/4885SMN1; SMN2 4735/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.